“We are pleased to welcome Darcy and Emily to Fortis,” said Dave King, CEO of Fortis Life Sciences. “Their exceptional leadership, strategic insight, and extensive industry expertise will further ...

Fortis trades near $58.50 at the time of writing. The stock is down about 8% from the 12-month high but is still up more than 8% over the past six months. Interest rate changes in Canada and the ...

Max Healthcare Institute Ltd. and Fortis Healthcare Ltd. are Jefferies' preferred picks in the hospital space in 2025, as it expects volume driven growth taking precedence and brownfield expansion ...